Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health Information Technology: Dos and Don'ts for Today and Tomorrow.

Managed care (Langhorne, Pa.)·2017

Same author

Just What the Doctor Ordered? Physician Participation in Health Care Organization Corporate Boards.

American journal of medical quality : the official journal of the American College of Medical Quality·2015

Same author

Best Practices for Health Outcomes Public Reporting.

Population health management·2015

Same author

Integrating scientific and real-world evidence within and beyond the drug development process.

Journal of comparative effectiveness research·2013

Same author

A predictive model of hospitalization risk among disabled medicaid enrollees.

The American journal of managed care·2013

Same author

Predictive models for diabetes patients in Medicaid.

Population health management·2011

Same journal

Changes in hospital readmissions for diabetes-related conditions. Differences by payer.

Managed care interface·2008

Same journal

A conversation with James K. Min, MD.

Managed care interface·2008

Same journal

Acute coronary syndromes.

Managed care interface·2008

Same journal

Improving outcomes in cardiovascular disease.

Managed care interface·2008

Same journal

The effect for oncology of the national coverage determination for erythropoiesis-stimulating agents.

Managed care interface·2008

Same journal

An evaluation of Washington's Medicaid disease-management program.

Managed care interface·2008

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Heart disease and managed care.

Managed Care Interface

|August 30, 2008

Summary

This summary is machine-generated.

Beta blockers have advanced cardiac care, but further interventions are needed. Health plans can leverage beta blocker success for other cardiovascular treatments like lipid management and antiplatelet therapies.

Related Experiment Videos

Last Updated: Jul 2, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Area of Science:

Cardiology
Health Management

Background:

Beta blockers have significantly improved cardiac care outcomes.
Heart disease continues to pose a substantial clinical and economic burden.

Purpose of the Study:

To identify areas for improved cardiovascular care interventions.
To guide managed care organizations (MCOs) in optimizing treatment strategies.

Main Methods:

Review of existing cardiovascular care interventions.
Analysis of the impact and cost-effectiveness of various therapies.

Main Results:

Beta blockers represent a successful model for cardiovascular intervention.
Further opportunities exist in long-term beta-blocker therapy, lipid disorder management, and antiplatelet use.

Conclusions:

Lessons from beta blocker success can be applied to other cardiovascular areas.
MCOs should consider expanding interventions in lipid and antiplatelet therapies.